Tissue Sealing Agents and Hemostasis Market

The global Tissue Sealing Agents and Hemostasis market was valued at US$ 3662.5 million in 2022 and is projected to reach US$ 4494.3 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Hemostasis is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing.
Tissue sealing agents are used during medical procedures to achieve hemostasis. They vary based on their mechanism of action, composition, ease of application, adherence to tissue, immunogenicity and cost. These agents permit rapid hemostasis, better Visualization of the surgical area, shorter operative times, decreased requirement for transfusions, decreased wound healing time and overall improvement in patient recovery time.
Tissue Sealing Agents and Hemostasis Market aims to provide a comprehensive presentation of the global market for Tissue Sealing Agents and Hemostasis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tissue Sealing Agents and Hemostasis. Tissue Sealing Agents and Hemostasis Market contains market size and forecasts of Tissue Sealing Agents and Hemostasis in global, including the following market information:
Global Tissue Sealing Agents and Hemostasis Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The classification of Hemostasis and Tissue Sealing Agents includes Hemostasis and Tissue Sealing Agents and the revenue proportion of Hemostasis Agent is about 64%.
Hemostasis and Tissue Sealing Agents is widely used for Minimally Invasive Surgery, General Surgery and other field. The most proportion of Hemostasis and Tissue Sealing Agents is used for general surgery, and the proprotion is 44%.
North America is the largest consumption place, with a consumption market share nearly 42%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is not intense. Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution and Pfizer, etc. are the leaders of the industry, with about 70% market shares.
We surveyed the Tissue Sealing Agents and Hemostasis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Natural Tissue Sealants
• Synthetic Tissue Sealants
• Others

• Academics
• Hospitals
• Laboratories
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Tissue Sealing Agents and Hemostasis revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Tissue Sealing Agents and Hemostasis revenues share in global market, 2022 (%)

• Advanced Medical Solutions Group plc
• Baxter
• Cohera Medical, Inc.
• CryoLife, Inc.
• C.R. Bard, Inc.
• Johnson & Johnson Services, Inc.
• Integra LifeSciences Corporation
• Pfizer, Inc.

Chapter 1: Introduces the definition of Tissue Sealing Agents and Hemostasis, market overview.
Chapter 2: Global Tissue Sealing Agents and Hemostasis market size in revenue.
Chapter 3: Detailed analysis of Tissue Sealing Agents and Hemostasis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tissue Sealing Agents and Hemostasis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.